Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma

Clinical trial NCT04365049 · UNKNOWN

Trial details

NCT number: NCT04365049
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Study type: OBSERVATIONAL

PDAC - Pancreatic Ductal Adenocarcinoma

Start date: 2020-04-01
Primary completion: 2023-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.